Third Wave s Net Loss Balloons in Q4 as Sales Decline and R&D Costs Surge | GenomeWeb

NEW YORK, Feb. 26 - Third Wave on Tuesday reported that a decline in product sales and a significant jump in R&D spending in the fourth quarter helped cause total revenue to fall slightly and net loss to balloon.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.